|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.40 HKD | -0.17% |
|
+2.01% | -3.23% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Development, Production, Marketing and Sale of Biopharmaceutical Products | 5.59B | 6.38B | 6.86B | 7.82B | 9.11B | |||||
Total Assets | 17.68B | 19.21B | 21.99B | 23.63B | 24.21B | |||||
Interest Expense | -81.07M | -66.52M | -101M | -212M | -191M | |||||
Income Tax Expense | 208M | 241M | 366M | 392M | 501M | |||||
CAPEX | -981M | -1.11B | -974M | -625M | -682M | |||||
EBT | 979M | 1.87B | 2.27B | 1.98B | 2.72B | |||||
Gross Profit | 4.52B | 5.28B | 5.67B | 6.64B | 7.83B | |||||
D&A | 361M | 329M | 382M | 335M | 395M | |||||
Net Income | 836M | 1.65B | 1.91B | 1.55B | 2.09B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Mainland China | 5.42B | 6.24B | 6.65B | 7.6B | 8.85B | |||||
Total Assets | 7.82B | 8.5B | 8.98B | 9.37B | 10.17B | |||||
Others | 167M | 141M | 209M | 217M | 257M | |||||
Total Assets | 2.06B | 2.02B | 2.18B | 2.25B | 1.96B |
- Stock Market
- Equities
- 1530 Stock
- Financials 3SBio Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition